S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Price:
286.78
CNY
12.46%
Market Closed
Market Cap:
¥118.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
CN |
|
John B Sanfilippo & Son Inc
NASDAQ:JBSS
|
US |
|
M
|
Manaksia Aluminium Co Ltd
NSE:MANAKALUCO
|
IN |
Multiples-Based Value
The Multiples-Based Value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 24.65 CNY. Compared to the current market price of 286.78 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 91%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
24.65
CNY
Overvaluation 91%
S
Multiples Across Competitors
Competitors Multiples
Sichuan Biokin Pharmaceutical Co Ltd Competitors
Sichuan Biokin Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
118.4B CNY | 53.2 | -138.9 | -142.8 | -142.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.8 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.5 | 16 | 9.9 | 12 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.5 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 20.2 | 7.8 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
